more-inMumbai: The 18-year-old girl from Patna, who won a court battle to get access to the highly controlled anti-TB drug bedaquiline, is recovering well. The Patna teenager is also one of the three patients in the hospital who have been put on another highly controlled and fairly new anti-TB drug called delamanid. “We are giving her a combination of bedaquiline and delamanid, along with a few other drugs,” said Dr. Udwadia, adding that another girl from Mumbai succumbed to the disease last month after getting delayed access to delamanid. Doctors say that the government needs to speed up the process of rolling out new anti-TB drugs. In 2012, Dr. Udwadia and his team had published a paper showing 12 TB patients resistant to all the available line of drugs.

Source: The Hindu March 16, 2017 19:30 UTC